Valuation : Enovis Corporation

Market Cap 1.1B 944M 889M 810M 1.52B 104B 1.52B 10.54B 4.07B 53.2B 4.12B 4.03B 169B P/E 2026 *
94.2x
P/E 2027 * 24.3x
Enterprise Value 2.4B 2.07B 1.95B 1.77B 3.32B 229B 3.33B 23.06B 8.91B 116B 9.02B 8.82B 369B EV / Sales 2026 *
1.03x
EV / Sales 2027 * 0.94x
Free-Float
98.36%
Yield 2026 *
-
Yield 2027 * -
1 day-4.75%
1 week-5.79%
Current month-22.61%
1 month-28.49%
3 months-20.58%
6 months-22.83%
Current year-28.57%
1 week 18.52
Extreme 18.52
20.22
1 month 18.52
Extreme 18.52
27.46
Current year 18.52
Extreme 18.52
31.66
1 year 18.52
Extreme 18.52
34.28
3 years 18.52
Extreme 18.52
65.03
5 years 18.52
Extreme 18.52
164.01
10 years 18.52
Extreme 18.52
164.01
Manager TitleAgeSince
Chief Executive Officer 61 12/05/2025
Director of Finance/CFO 47 01/01/2023
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 55 13/05/2008
Director/Board Member 67 21/09/2010
Chairman 64 21/05/2025
Date Insider Type Main position Quantity % Market Cap. Importance
4/9/26 Buy

Chief Executive Officer

13,035 0.0228%
3/9/26 Buy

Chief Administrative Officer

5,140 0.0090%
30/6/26 Free

Director

846 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-4.75%-5.79% - - 1.1B
Average -4.75%
Weighted average by Cap. -4.75%

Financials

2026 *2027 *
Net sales 2.34B 2.01B 1.9B 1.73B 3.23B 223B 3.24B 22.47B 8.68B 113B 8.79B 8.59B 359B 2.45B 2.11B 1.99B 1.81B 3.39B 234B 3.4B 23.57B 9.11B 119B 9.22B 9.02B 377B
Net income 11.32M 9.75M 9.18M 8.36M 15.64M 1.08B 15.71M 109M 42.03M 549M 42.53M 41.6M 1.74B 39M 33.56M 31.6M 28.79M 53.87M 3.71B 54.09M 375M 145M 1.89B 146M 143M 5.99B
Net Debt 1.3B 1.12B 1.06B 963M 1.8B 124B 1.81B 12.52B 4.84B 63.23B 4.9B 4.79B 200B 1.21B 1.04B 982M 895M 1.67B 115B 1.68B 11.64B 4.5B 58.78B 4.55B 4.45B 186B
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
09/09/26 US$19.03 -4.75% 1,879,438
08/09/26 US$19.98 +7.65% 3,743,670
04/09/26 US$18.56 -4.33% 1,886,851
03/09/26 US$19.40 -3.96% 2,331,206
02/09/26 US$20.20 -1.61% 2,475,014
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
19.03USD
Average target price
38.33USD
Spread / Average Target
+101.44%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!